2nd Annual Genome Editing USA Congress

May 10-11th,2018 ∣ Boston,USA

 

As we are approaching our highly anticipated 2nd Annual Genome Editing USA Congress we wanted to share with you the latest updates regarding the conference programme. You will network and learn valuable insights into this rapidly advancing industry; discuss the key areas that are shaping the market including today, including:

 

• how to use platforms such as CRISPR for therapeutic applications

• utilising genome editing in drug discovery and development

• steps being taken to cure human disease through gene editing.

 

Do not miss out on the latest speaker updates:

 

• CRISPR/Cas9 As A Tool For Drug Discovery by Tom Barnes, Chief Scientific Officer, Intellia Therapeutics

• Dissecting The Causal Mechanism Of X-Linked Dystonia-Parkinsonism By Integrating Genome And Transcriptome Assembly by Christopher Bragg, Director of Research for the Collaborative Center for X-linked Dystonia Parkinsonism, Massachusetts General Hospital

• Modeling Human Disease With Transgenic Drosophila CRISPR Libraries by Jonathan Zirin, Assistant Director of DRSC/TRiP-FGR, Harvard Medical School

 

VIEW THE AGENDA: http://bit.ly/2hpk5Pn

GENOME EDITING US LIVE WEBINARS:

 

• Genome Editing – Tools and Technologies for Drug Discovery and Bioinformatics Presented by Niren Murthy and Danilo Maddalo Register for free today >>

• Chemically Enhancing Genome Editing Technologies, and Mechanisms of Precise Genome Engineering in Human Somatic Cells Presented by Eric Hendrickson and Katherine Pawelczak Register for free today >>

 

Contact us

Kelly MacKenzie

Marketing Assistant

Tel: +441865248455

Email: k.mackenzie@oxfordglobal.co.uk

Website: http://www.genomeeditingusa-congress.com/